ஒன்றுபட்டது சிகிச்சை நிறுவனம் நாஸ்டாக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒன்றுபட்டது சிகிச்சை நிறுவனம் நாஸ்டாக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒன்றுபட்டது சிகிச்சை நிறுவனம் நாஸ்டாக் Today - Breaking & Trending Today

United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference

United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021

United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference


United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 25, 2021 /PRNewswire/  United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company s business during a fireside chat session at the Jefferies Virtual Healthcare Conference.
The session will take place virtually on Tuesday, June 1, 2021, from 3:30 p.m. to 3:55 p.m., Eastern Daylight Time, and can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed at the same location for 90 days. ....

Dewey Steadman , James Edgemond , Exchange Commission , United Therapeutics Corporation Nasdaq , United Therapeutics Corporation , Chief Financial Officer , United Therapeutics , Jefferies Virtual Healthcare , Eastern Daylight Time , Therapeutics Corporation , Lung Biotechnology , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Further Information Contact , டெவெய் நிலையான , பரிமாற்றம் தரகு , ஒன்றுபட்டது சிகிச்சை நிறுவனம் நாஸ்டாக் , ஒன்றுபட்டது சிகிச்சை நிறுவனம் , தலைமை நிதி அதிகாரி , ஒன்றுபட்டது சிகிச்சை , ஜெஃப்பெரிஸ் மெய்நிகர் சுகாதாரம் , கிழக்கு பகல் நேரம் , சிகிச்சை நிறுவனம் , நுரையீரல் உயிரி தொழில்நுட்பவியல் ,

United Therapeutics Corporation : Reports First Quarter 2021 Financial Results


Message :
Required fields
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 5, 2021 /PRNewswire/  United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2021. Total revenue in the first quarter of 2021 grew 6% year over year to $379.1 million, compared to $356.3 million in the first quarter of 2020.
2021 is already a historic year for United Therapeutics, with the recent FDA approval and launch of Tyvaso for treatment of PH-ILD, submission of the Tyvaso DPI NDA, and the launch of our Remunity
® Pump for Remodulin
®, said Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics. In addition to these product launches and the potential Tyvaso DPI approval in December, we are progressing our late-stage pipeline with the commencement of the pivotal ....

United States , Michael Benkowitz , Eli Lilly , Dewey Steadman , Martine Rothblatt , Exchange Commission , United Therapeutics Corporation Nasdaq , Research Development Corp , United Therapeutics Corporation , United Therapeutics , Chief Executive Officer , Chief Operating Officer , Remunity Pump , Remodulin In February , Inhalation Solution , New England Journal , Tyvaso Inhalation , Tyvaso Inhalation Solution , Stock Incentive Plan , Current Report , Nasdaq Listing Rule , Therapeutics Corporation , Lung Biotechnology , Private Securities Litigation Reform Act , Implantable System , Annual Report ,